Modulation of cardiac optogenetics by vitamin A

Biofactors. 2019 Nov;45(6):983-990. doi: 10.1002/biof.1564. Epub 2019 Sep 11.

Abstract

Cardiac optogenetics is an emergent research area and refers to the delivery of light-activated proteins to excitable heart tissue and the subsequent use of light for controlling the electrical function with high spatial and temporal resolution. Channelrhodopsin-2 (ChR2) is a light-sensitive ion channel with the chromophore, all trans retinal, derived from vitamin A (all-trans-retinol; retinol). In this study, we explored whether exogenous vitamin A can be a limiting factor in the light responsiveness of cardiomyocytes-expressing ChR2. We showed that in cardiomyocytes virally transduced with ChR2 (H134R)-enhanced yellow fluorescent protein, vitamin A supplements lower than 10 μM significantly increased ChR2 expression. Adding 1 μM vitamin A changed light-induced transmembrane potential difference significantly, whereas 5 μM dramatically induced membrane depolarization and triggered intracellular calcium elevation. We concluded that vitamin A supplementation can modulate the efficiency of ChR2 and provide a complementary strategy for improving the performance of optogenetic tools.

Keywords: cardiac optogenetics; channelrhodopsin-2; optogenetics; vitamin A.

MeSH terms

  • Animals
  • Animals, Newborn
  • Calcium / metabolism
  • Carrier Proteins / genetics*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / radiation effects
  • Light Signal Transduction / drug effects
  • Membrane Potentials / drug effects
  • Membrane Potentials / radiation effects
  • Myocardium / metabolism*
  • Myocytes, Cardiac / drug effects
  • Myocytes, Cardiac / metabolism
  • Myocytes, Cardiac / radiation effects
  • Optogenetics*
  • Rats
  • Vitamin A / pharmacology*

Substances

  • Carrier Proteins
  • channelopsin-2, Chlamydomonas reinhardtii
  • Vitamin A
  • Calcium